164 related articles for article (PubMed ID: 162922)
1. Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model.
Marks MI
J Infect Dis; 1975 Jan; 131(1):11-6. PubMed ID: 162922
[TBL] [Abstract][Full Text] [Related]
2. The chemotherapy of viral infections.
Weinstein L; Chang TW
N Engl J Med; 1973 Oct; 289(14):725-30. PubMed ID: 4353783
[No Abstract] [Full Text] [Related]
3. Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine.
Allen LB; Sidwell RW
Antimicrob Agents Chemother; 1972 Sep; 2(3):229-33. PubMed ID: 4790562
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus encephalitis: therapy trials.
Lerner AM; Lauter CB; Nolan DC
Ann Intern Med; 1973 Aug; 79(2):285. PubMed ID: 4726549
[No Abstract] [Full Text] [Related]
5. Treatment of herpes simplex virus types 1 and 2 encephalitis in mice with 9-beta-D-arabinofuranosyladenine.
Sloan BJ; Miller FA; McLean IW
Antimicrob Agents Chemother; 1973 Jan; 3(1):74-80. PubMed ID: 4790577
[TBL] [Abstract][Full Text] [Related]
6. Anti-herpesvirus action of isoprinosine.
Gordon P; Ronsen B; Brown ER
Antimicrob Agents Chemother; 1974 Feb; 5(2):153-60. PubMed ID: 4365114
[TBL] [Abstract][Full Text] [Related]
7. Experimental herpes simplex encephalitis. Treatment with pyrimidine nucleosides.
Panitch HS; Baringer JR
Arch Neurol; 1973 Jun; 28(6):371-5. PubMed ID: 4349629
[No Abstract] [Full Text] [Related]
8. Failure of high dose 5-iodo-2'-deoxyuridine in the therapy of herpes simplex virus encephalitis. Evidence of unacceptable toxicity.
;
N Engl J Med; 1975 Mar; 292(12):599-603. PubMed ID: 1089874
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds.
Klein RJ; Friedman-Kien AE; Brady E
Antimicrob Agents Chemother; 1974 Mar; 5(3):318-22. PubMed ID: 4840439
[TBL] [Abstract][Full Text] [Related]
10. Experimental herpes simplex virus encephalitis: Comparative effects of treatment with cytosine arabinoside and adenine arabinoside.
Griffith JF; Fitzwilliam JF; Casagrande S; Butler SR
J Infect Dis; 1975 Nov; 132(5):506-10. PubMed ID: 171318
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis and therapy of experimental ocular herpes simplex. Comparison of idoxuridine, adenine arabinoside, and hypoxanthine arabinoside.
Pavan-Langston D; Langston RH; Geary PA
Arch Ophthalmol; 1974 Nov; 92(5):417-21. PubMed ID: 4611395
[No Abstract] [Full Text] [Related]
12. Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients.
Chow AW; Roland A; Fiala M; Hryniuk W; Weil ML; Geme JS; Guze LB
Antimicrob Agents Chemother; 1973 Mar; 3(3):412-7. PubMed ID: 4790599
[TBL] [Abstract][Full Text] [Related]
13. Antiviral drugs for the neonate--the risk-benefit ledger.
Brunell P
J Pediatr; 1975 Feb; 86(2):317-8. PubMed ID: 163110
[No Abstract] [Full Text] [Related]
14. Experimental herpes simplex virus encephalitis. Effect of corticosteroids and pyrimidine nucleoside.
Baringer JR; Klassen T; Grumm F
Arch Neurol; 1976 Jun; 33(6):442-6. PubMed ID: 180935
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA
Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191
[TBL] [Abstract][Full Text] [Related]
16. Herpes encephalitis: controlled studies.
Hirsch MS; Levin M; Chien LT
Ann Intern Med; 1973 May; 78(5):779. PubMed ID: 4711782
[No Abstract] [Full Text] [Related]
17. Intranasal challenge of mice with herpes simplex virus: an experimental model for evaluation of the efficacy of antiviral drugs.
De Clercq E; Luczak M
J Infect Dis; 1976 Jun; 133 Suppl():A226-36. PubMed ID: 180205
[TBL] [Abstract][Full Text] [Related]
18. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study.
Whitley RJ; Soong SJ; Dolin R; Galasso GJ; Ch'ien LT; Alford CA
N Engl J Med; 1977 Aug; 297(6):289-94. PubMed ID: 195208
[TBL] [Abstract][Full Text] [Related]
19. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.
de Clercq E; Zhang ZX; Sim IS
Antimicrob Agents Chemother; 1982 Sep; 22(3):421-5. PubMed ID: 7137983
[TBL] [Abstract][Full Text] [Related]
20. Neonatal disseminated herpes simplex virus infection with encephalitis treated with cytosine arabinoside.
Brown RS; Bower BD
Dev Med Child Neurol; 1975 Aug; 17(4):493-8. PubMed ID: 1158055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
